Direct effects of the monovalent cation ionophores monensin and nigericin on myocardium.
D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002415:Cats; D005260:Female; D005663:Furans / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007476:Ionophores / Q000494:pharmacology*; D008297:Male; D008985:Monensin / Q000494:pharmacology*; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D009550:Nigericin / Q000494:pharmacology*; D010210:Papillary Muscles / Q000187:drug effects; D010725:Phosphocreatine / Q000378:metabolism; D011690:Purkinje Fibers / Q000187:drug effects
D000900:Anti-Bacterial Agents; D005663:Furans; D007476:Ionophores; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D008985:Monensin; D009550:Nigericin